These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32931158)

  • 1. Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single-institution study of more than 27,000 cases.
    Tian W; Shore KT; Shah RB
    Cancer Cytopathol; 2021 Feb; 129(2):114-120. PubMed ID: 32931158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
    Vlajnic T; Gut A; Savic S; Bubendorf L
    J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].
    Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of The Paris System (TPS) for upper urinary tract cytopathology: correlation with histology follow-up and UroVysion fluorescence in situ hybridization (FISH) analysis.
    Jia L; Rood T; Kirkpatrick J; Sarode V
    J Am Soc Cytopathol; 2024; 13(2):149-155. PubMed ID: 38341300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
    Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
    BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
    Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS
    Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
    Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
    Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical application of the Paris system for reporting urinary cytology].
    Chen L; Liu LT; Sun MJ; He SR; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):470-476. PubMed ID: 38678328
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion
    Miki Y; Neat M; Chandra A
    Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation study of the Paris system for reporting urinary (TPS) categories.
    Pierconti F; Martini M; Cenci T; Fiorentino V; Sacco E; Bientinesi R; Pugliese D; Iacovelli R; Schinzari G; Larocca LM; Bassi PF
    J Clin Pathol; 2021 Feb; 74(2):102-105. PubMed ID: 32527754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Wang Y; Auger M; Kanber Y; Caglar D; Brimo F
    Cancer Cytopathol; 2018 Mar; 126(3):207-214. PubMed ID: 29278461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of implementing the first edition of the Paris system for reporting: A systematic review and meta-analysis.
    Farahani SJ; Li J; Minder B; Vielh P; Glisic M; Muka T
    Cytopathology; 2024 Sep; 35(5):616-633. PubMed ID: 38934101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
    Goutas D; Savvidou K; Vrettou K; Meletis E; Levis P; Constantinides C; Lazaris AC; Mikou P
    Cytopathology; 2021 Nov; 32(6):795-801. PubMed ID: 34289188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
    Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
    Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year of experience using the Paris System for Reporting Urinary Cytology.
    Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
    Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
    Pastorello RG; Barkan GA; Saieg M
    J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.